Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 24, 2026 08:30 ET | Source: Alvotech

Alvotech birtir uppgjör fyrsta ársfjórðungs 2026 þann 6. maí nk.

REYKJAVÍK (24. apríl 2026) – Alvotech (NASDAQ: ALVO) mun birta uppgjör fyrsta ársfjórðungs 2026 þann 6. maí nk., eftir lokun markaða í Bandaríkjunum. Fundur til kynningar á uppgjörinu verður sendur út...
April 24, 2026 08:30 ET | Source: Alvotech

Alvotech to Report Financial Results for the First Quarter of 2026

REYKJAVIK, ICELAND (April 24, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for...
April 24, 2026 08:30 ET | Source: NetworkNewsWire

NetworkNews Audio Announces Audio Press Release (APR) Discussing Advancing Oncology Therapeutics, Strategic Positioning within High-Value Development Pathways

AUSTIN, Texas, April 24, 2026 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving...
April 22, 2026 08:30 ET | Source: BioMedWire

Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition

AUSTIN, Texas, April 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: The biotechnology industry is experiencing a subtle yet meaningful transformation that is redefining how value is...
April 20, 2026 08:30 ET | Source: BioMedWire

When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech

AUSTIN, Texas, April 20, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Biotechnology is undergoing a quiet but profound transformation, one that is reshaping how investors understand value...
April 09, 2026 07:00 ET | Source: Medicenna Therapeutics Corp.

Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim as Chief Medical Officer

TORONTO and HOUSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company...
March 30, 2026 19:58 ET | Source: Alvotech

Alvotech birtir ársreikning á eyðublaði 20-F

REYKJAVIK (30. mars 2026) — Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að fyrirtækið hefði birt ársreikning fyrir fjárhagsárið 2025 á eyðublaði 20-F í samræmi við reglur Verðbréfaeftirlits...
March 30, 2026 19:58 ET | Source: Alvotech

Alvotech files Annual Report with the SEC

REYKJAVIK, ICELAND (March 30, 2026) — Alvotech (NASDAQ: ALVO) (the “Company”) has filed its Annual Report 2025 on Form 20-F for the financial year 2025 with the U.S. Securities and Exchange Commission...
March 30, 2026 19:55 ET | Source: Alvotech

Alvotech birtir ársskýrslu fyrir árið 2025

REYKJAVIK (30. mars 2026) — Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að fyrirtækið hefði birt ársskýrslu fyrir árið 2025. Skýrslan er aðgengileg á fjárfestasíðu...
March 30, 2026 19:55 ET | Source: Alvotech

Alvotech Publishes 2025 Annual Report

REYKJAVIK, ICELAND (March 30, 2026) — Alvotech (NASDAQ: ALVO) (the “Company”) has published its Annual Report for 2025. The report is available in the investor relations section of Alvotech’s website...